Based on available data, the COVID 19,including the use of hydroxychloroquine

Based on available data, the COVID 19 Solidarity Trial Data Safety & Monitoring Committee recommended there are no reasons to modify the trial protocol. The Executive Group endorsed the continuation of all arms of the Trial, including the use of hydroxychloroquine